PolyPid
PYPD • NASDAQ
PolyPid is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dikla Czaczkes Akselbrad, with a market cap of $83.4M.
Market Cap$83.4M
Employees62.0
CEODikla Czaczkes Akselbrad
CountryIsrael
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
PolyPid FAQ
Common questions about PolyPid
PolyPid is scheduled to report earnings for Q1 2026 on May 13, 2026.
PolyPid has approximately 62 employees.